Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun Fan

Showing results (801-810 of 920) with videos related to

Pageof 92
Sort By:
Translational Psychiatry|June 25, 2025
Identification of novel therapeutic targets for cognitive performance and associations with brain healthLu-Yang Zhang, Yu-Xin Liu, Yun-Hui Chu, et al.
Thoracic Cancer|June 8, 2025
Chinese Expert Consensus on Leptomeningeal Metastases of Lung CancerGen Lin, Yongsheng Wang, Tao Xin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 28, 2025
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: A Pilot StudyYang Hua, Meng-Huan Li, Ting-Ting Wu, et al.
Journal of Cancer|August 17, 2019
KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal TransitionBo Hu, Jian-Wen Cheng, Jin-Wu Hu, et al.
EMBO Molecular Medicine|February 27, 2024
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravisDai-Shi Tian, Chuan Qin, Ming-Hao Dong, et al.
British Journal of Cancer|September 17, 2019
Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective studyYanjun Xu, Zhiyu Huang, Hongyang Lu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 3, 2024
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancerByoung Chul Cho, Chao-Hua Chiu, Erminia Massarelli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2006
Chronic hepatitis B: a critical appraisal of current approaches to therapyRobert P Perrillo, Robert G Gish, Marion Peters, et al.
Frontiers in Public Health|July 3, 2026
Life-course BMI trajectories and long-term weight gain in relation to hepatic steatosis in a rural community-based cohort in Southwest ChinaXian Cui, Jinjie Xu, Jian Wang, et al.
Nature Medicine|August 12, 2022
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trialVivek Subbiah, Philippe A Cassier, Salvatore Siena, et al.
Pageof 92

Showing results (801-810 of 920) with videos related to

Sort By:
Pageof 92
Translational Psychiatry|June 25, 2025
Identification of novel therapeutic targets for cognitive performance and associations with brain healthLu-Yang Zhang, Yu-Xin Liu, Yun-Hui Chu, et al.
Thoracic Cancer|June 8, 2025
Chinese Expert Consensus on Leptomeningeal Metastases of Lung CancerGen Lin, Yongsheng Wang, Tao Xin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 28, 2025
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: A Pilot StudyYang Hua, Meng-Huan Li, Ting-Ting Wu, et al.
Journal of Cancer|August 17, 2019
KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal TransitionBo Hu, Jian-Wen Cheng, Jin-Wu Hu, et al.
EMBO Molecular Medicine|February 27, 2024
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravisDai-Shi Tian, Chuan Qin, Ming-Hao Dong, et al.
British Journal of Cancer|September 17, 2019
Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective studyYanjun Xu, Zhiyu Huang, Hongyang Lu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 3, 2024
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancerByoung Chul Cho, Chao-Hua Chiu, Erminia Massarelli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2006
Chronic hepatitis B: a critical appraisal of current approaches to therapyRobert P Perrillo, Robert G Gish, Marion Peters, et al.
Frontiers in Public Health|July 3, 2026
Life-course BMI trajectories and long-term weight gain in relation to hepatic steatosis in a rural community-based cohort in Southwest ChinaXian Cui, Jinjie Xu, Jian Wang, et al.
Nature Medicine|August 12, 2022
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trialVivek Subbiah, Philippe A Cassier, Salvatore Siena, et al.
Pageof 92